Similarly, this study demonstrates the complexity surrounding SR-B1 context-dependent functionality; although it has long been thought to be primarily an atheroprotective mediator of RCT via HDL-c binding, SR-B1 can contribute negatively towards atherosclerosis progression in CVD through a multitude of pathways (Fig. 3). The gene discussed is SCARB1; the disease is atherosclerosis.